Click on the links below to view active TRND projects:
- Antifibrotic Therapy for the Treatment of Pulmonary Hypertension
- Bone Morphogenetic Protein Inhibitors to Treat Fibrodysplasia Ossificans Progressiva
- Development of Acoziborole for the Treatment of Human African Trypanosomiasis
- Development of Malaria Transmission-Blocking Drugs
- Gene Therapy for the Treatment of AADC Deficiency
- Gene Therapy for the Treatment of Pompe Disease
- Inhaled GM-CSF Therapy for Autoimmune Pulmonary Alveolar Proteinosis
- LUM-001 as a Treatment for Creatine Transporter Deficiency
- A Novel Compound for Targeted Treatment of Core Binding Factor Leukemia
- Novel Treatment for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
- A Protein Replacement Drug for Friedreich’s Ataxia
- Repurposing an EU Therapeutic for Hemoglobinopathies
- Repurposing of a Long-Acting Parathyroid Hormone Analog for the Treatment of Hypoparathyroidism
- Therapy for Fuchs Endothelial Corneal Dystrophy
- A Treatment for Patients with Jansen’s Metaphyseal Chondrodysplasia
- Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with Noonan Syndrome with Multiple Lentigines (NSML)
NCATS and Duke University scientists help